SciClone Pharmaceuticals Inc. Sets New 1-Year Low at $4.25 (SCLN)
SciClone Pharmaceuticals (NASDAQ:SCLN)’s share price reached a new 52-week low on Tuesday, American Banking News.com reports. The company traded as low as $4.25 and last traded at $5.18, with a volume of 825,411 shares traded. The stock had previously closed at $4.49.
Separately, analysts at Aegis cut their price target on shares of SciClone Pharmaceuticals from $9.00 to $8.00 in a research note to investors on Tuesday, November 12th. They now have a “buy” rating on the stock.
SciClone Pharmaceuticals has a 52 week low of $4.29 and a 52 week high of $6.30. The stock has a 50-day moving average of $5.06 and a 200-day moving average of $5.17. The company has a market cap of $278.4 million and a P/E ratio of 19.61.
SciClone Pharmaceuticals (NASDAQ:SCLN) last announced its earnings results on Tuesday, November 12th. The company reported $0.18 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.15 by $0.03. The company had revenue of $35.20 million for the quarter, compared to the consensus estimate of $39.70 million. During the same quarter in the previous year, the company posted ($0.24) earnings per share. The company’s revenue for the quarter was down 13.5% on a year-over-year basis. On average, analysts predict that SciClone Pharmaceuticals will post $0.35 earnings per share for the current fiscal year.
SciClone Pharmaceuticals, Inc (NASDAQ:SCLN) is a specialty pharmaceutical company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.